Agoracom Blog Home

Posts Tagged ‘stocks’

Else Nutrition $BABY.ca Announces North American Launch of World’s Only Real Alternative to Dairy-Based Baby Nutrition $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:22 AM on Tuesday, August 11th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Baby Nutrition Paradigm shift: After 120 years, Else introduces a completely novel protein source for baby nutrition (over one year old) with a breakthrough, clean and sustainable production process.
  • Globally patented, and founded by infant nutrition industry veterans, Else Nutrition is the first dairy and soy- free, clean label, plant-based complete nutrition for babies (1 year and over).
  • A Revolution in the way babies are fed, Else Nutrition offers parents a great- tasting, dairy-free, soy-free and GMO-free alternative.
  • Else Plant-Based Complete Nutrition is now available for purchase at elsenutrition.com, U.S. shipping nationwide and to Canada.

VANCOUVER, BC / August 11, 2020 / ELSE NUTRITION HOLDINGS INC. (TSX-V:BABY) (OTCQX:BABYF) (FSE:0YL) (“Else” or the “Company“), today announces the online product launch of its Else Plant-Based Complete Toddler Nutrition, the first fully certified USDA Organic, Clean Label, Plant-Based, Soy-Free nutritional drink for toddlers. Made with ingredients, vitamins and minerals that help support growth and development after a baby’s first year. Else Plant-Based Complete Nutrition is the only globally-patented, real alternative for babies beyond the first year – including those with milk intolerances/sensitivities, those looking to avoid dairy and soy, and for all families looking for a clean, plant-based option for their children

Dairy-free, soy-free, corn syrup-free, gluten-free and non-GMO, Else Nutrition is a unique globally patented combination of whole-plant organic ingredients – almonds buckwheat and tapioca. This combination meets the gold standard equivalent of human milk nutritional composition values, based on WHO international standards, among others. Else Plant- Nutrition meets the strictest regulatory requirements and the highest nutrition standards, providing a full essential amino acid profile and a clean source of protein. It is manufactured in an infant grade U.S. manufacturing site and endorsed by a board of leading U.S. and international pediatricians and nutritionists.

“We are thrilled that today marks a huge leap forward in plant-based alternatives in the baby and toddler category,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “For more than 120 years, cow’s milk and soy have dominated. After seven years of R&D, we are finally able to offer something else to parents and bring a real, clean label alternative to families across North America, so that they will never have to compromise on the health and nutrition of their toddler again.”

Else Plant-Based Complete Nutrition for Toddlers is minimally processed. Else intends for all its future products to meet this standard. With more than seven years of research and development, Else’s breakthrough process creates nutrition products from whole plants without altering their chemistry or using highly-processed extracts, or harsh chemicals. Through this disruptive process, Else is able to maximize the nutritional value and minimize environmental impact.

Additionally, Else Nutrition’s innovation pipeline includes a breakthrough, plant-based, clean label infant formula for babies 0-12 months. It is anticipated to launch in approximately two years, currently on its pathway for final FDA approval.

Beyond the brand’s Advisory Board of Pediatricians and nutritionists, Else has already captured the attention of many influential mothers, such as Hilaria Baldwin. As a mother of four with the fifth on the way, Hilaria came across Else as she searched for nutrition products for her toddler Romeo. After using the product, Hilaria decided to partner with Else to support its product launch.

Else Plant-Based Complete Nutrition for Toddlers is now available at elsenutrition.com, currently priced at $36 for a single 22 oz. powder canister and $136 for a 4-pack. The product will also be offered on Amazon.com later this month and in select retail chains sometime during Q4 2020.

Disruptive,Beyond Organic’ Production Process

Else products are minimally processed, using the cleanest production process in the infant nutrition industry. Else’s ‘Beyond Organic’ disruptive manufacturing process transforms whole plants to tasty toddler nutrition, without using highly-processed extracts or derivatives, harsh chemicals, or high-fructose corn syrup. Changing only the texture of the plants, and never the fundamental chemistry, allowing for more of the nutrients that nature intended to nourish the child.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media Contact:

Covet Consumer Business Unit
Gianna Totaro
[email protected]
P: 1-301-875-6574

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will,” “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

VIDEO: Vegaste Technologies $VEGA.ca Closes 1st Day Of Trading With $75,000,000 Market Cap & Revenue Run Rate Of $US 3,000,000

Posted by AGORACOM-JC at 8:02 PM on Monday, August 10th, 2020
PlantX | LinkedIn

AGORACOM prides itself on becoming the discovery platform of emerging disruptive companies …. and we’ve discovered another one today in Vegaste Technologies, an e-commerce driven platform that is delivering all things plant-based to customers across Canada right now.    

Vegaste has already started with both plant-based food meals directly to homes, thanks to partnerships right across the country – but isn’t stopping there as it adds hundreds of products to the platform.  More than just lip service, Vegaste is already on a $US 3,000,000 run rate and that will probably accelerate in the coming months as marketing and additional products kick in.  

Vegaste Founder, Sean Dollinger, is no stranger to AGORACOM followers as he was the Co-Founder behind wildly successful Namaste Technologies before it fell on hard times experienced by the cannabis industry.  In addition to bringing back his immense e-commerce capabilities, he’s also implemented some valuable lessons learned at Namaste when it comes to corporate governance and share structure.  

One of those lessons was appointing Julia Frank as CEO and giving her the team necessary to focus on doing the best job possible.  Julia’s experience combines both start-up and big corporation structures thanks to being part of start-up teams within both BMW and Daimler in Germany.    

Vegaste is hot off the listing press, so if you ever wanted to get a jump on your fellow investor it doesn’t get much fresher than this ….. unless you’re ordering a plant based meal off their platform at www.PlantX.com

If you believe in the paradigm shifting nature of plant based foods, be sure to watch and share this great interview with Vegaste CEO Julia Frank CEO & Founder Sean Dollinger.

Avicanna Inc. $AVCN.ca to Host Second Quarter 2020 Investor Conference Call $CRDL.ca $PCLO.ca $WEED.ca $ACB.ca

Posted by AGORACOM-JC at 6:46 PM on Friday, August 7th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

TORONTO, Aug. 7, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it has scheduled a conference call on Monday, August 17, 2020 at 9:00AM Eastern Time to discuss the results for its fiscal second quarter ended June 30, 2020. Aras Azadian, Chief Executive Officer and Davender Sohi, Chief Financial Officer, will host the call and a question and answer period. The Company will report its financial results for the second quarter after the close of markets on Friday, August 14, 2020.

            Conference Call Details

DATE:                                           August 17, 2020                                   
TIME:  9:00 AM Eastern Time
  
CONFIRMATION #:                             64751998
  
TORONTO:                                           416-764-8659
NORTH AMERICAN TOLL FREE:         1-888-664-6392
GERMANY TOLL FREE:   08007240293
COLOMBIA TOLL FREE:      018005184036
  
REPLAY TORONTO:                             416-764-8677  
REPLAY NORTH AMERICA:    1-888-390-0541 
REPLAY ENTRY CODE:   751998#
REPLAY EXPIRATION DATE:               August 24, 2020

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated April 15, 2020 (the “AIF“) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE Avicanna Inc.

Innocan’s $INNO.ca SHIR (TM) Beauty & Science #CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:45 PM on Thursday, August 6th, 2020
Innocan-Blog
  • Announced that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union
  • SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results
  • The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum

Herzliya, Israel and Calgary, Alberta–(August 6, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union.

SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results. The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum.

Innocan’s SHIR™ Beauty & Science CBD Derma Cosmetics

https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg



To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg

“As a Pharma Company, Innocan is committed to creating premium products that meet the highest quality standards to provide consumer confidence,” Iris Bincovich, co-founder and CEO of Innocan states. “Compliance with EU regulation is a major milestone for us, following the receipt of technical validation from the FDA for the marketing in the US of our over-the-counter Relief & Go Pain Relief spray, a few weeks ago. The next step is to initiate our various distribution platforms to deliver our SHIR™ CBD Derma Cosmetic line across the European Union and other markets where legally permitted to do so.”

About Innocan

The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release Liposome to be administrated by Injection. The Company plans, together with Prof. Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University to test the Liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, the effectiveness and safety of the Company’s products, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

VIDEO – ImagineAR $IP.ca $IPNFF Adds Media Powerhouse Michael Anderson To Spearhead UK & Euro Sales $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 4:30 PM on Thursday, August 6th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

If you were a small cap Augmented Reality company from Vancouver that needed to appoint an old media / new media powerhouse to head up your European sales operations, we really don’t think you could have found someone better credentialed than Michael Anderson – and that’s exactly what ImagineAR (IP:CSE) (IPNFF:OTCQB) did.  

Anderson is a highly regarded leader in the world of digital with his roots firmly based in UK media. Part entrepreneur, part corporate animal, he quickly rose through the ranks ending up as Managing Director of News UK. He worked for Rupert Murdoch and Les Hinton during his rise to the top and made the Board room of both News UK and Associated Newspapers (publishers of the Daily Mail).   

Sensing the changing winds of the media business, Anderson was a driving force on the launch team of Metro, which overtook The Sun in 2018 as the largest circulation of any newspaper in the UK.  At Metro, he was instrumental in the paper being cited as a new business case with commercial results not seen previously in the newspaper industry, growing revenue from £100k a week to £1m per week in just 12 months.  Additionally, Mike was the founder of the Chelsea APPS Factory which included UK clients KPMG, Ladbrokes, Standard Life, TfL, Vanquis and Waitrose.    

….. And now he is sensing another change in the winds to put his considerable talents and team behind the Augmented Reality solutions of ImagineAR.  

If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:  

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”  

 Anderson wholeheartedly agrees, stating “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in the UK and Europe.”  

That quote is just the tip of the iceberg.  Watch what Anderson has to say about the “unlimited possibilities of Augmented Reality” and some pretty good hints about whose doors he will be knocking on first …. which is pretty impressive given the fact August is vacation season in Europe 🙂   

If our interview with CEO Alen Paul Silverrstieen and Michael Anderson is any indication, it sounds like the Company’s growth into the UK and Europe is all but assured in 2020 and well beyond.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Else Nutrition $BABY.ca Provides Corporate Update $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 1:02 PM on Thursday, August 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020
  • A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner
  • The Company’s Amazon.com store will launch in the coming weeks

VANCOUVER, BC /August 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

“Our team has been working relentlessly, during an unprecedently difficult time, to bring our product to market. As we get set to launch, we are beyond thrilled to have crossed major hurdles over the past months and weeks – including full scale manufacturing with a U.S. based partner and mobilization of our U.S. supply chain which has culminated in our ability to ship samples of our plant-based formula for toddlers to eager parents across North America,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

North America Launch

The Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020. A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner. The Company’s Amazon.com store will launch in the coming weeks.

U.S. Manufacturing

The first full-scale commercial manufacturing run of the toddler nutrition powder product was successfully completed by the Company’s U.S. manufacturing partner and packed at a co-packer plant in Nevada.

The terms of the U.S. manufacturing agreement have been negotiated and a formal agreement will be executed upon the receipt of final yield and cost optimization parameters. The next commercial manufacturing run is booked and secured.

FDA Regulatory Pathway

The Company in conjunction with its FDA consulting partner continues to progress on the regulatory pathway for multiple products including an infant formula and new products currently in development for the adult nutrition market.

Health and Happiness International Holdings Limited

The Company’s negotiations with its strategic partner, H&H Global, for distribution rights of the toddler and infant formula in France are advancing well. The parties are studying the target market needs, channels, and regulations, in addition to preparing a launch plan and negotiating the distribution terms. Additionally, discussions regarding distribution in additional markets have also commenced.

Cash and Runway

The company is well capitalized, with approximately CAD$7.0 million in cash, and no short or long-term debt, to fully support its manufacturing and go-to-market plans for the next 12 months.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

If you’re an investor in Aurora Cannabis $ACB Check out our recent interview with Avicanna $AVCN.ca

Posted by AGORACOM-JC at 5:25 PM on Tuesday, August 4th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

MEDICAL CANNABIS

  • Medical Cannabis 2.0 – Superior Products To Products Currently On The Market
    • Evidence Backed Medical Cannabis So Doctors Can Prescribe With Confidence
  • Launch Across Canada Immanent
  • Exclusive Distribution Through Online Store Of Shoppers Drug Mart
  • Global Distribution Through US, U.K, Australia, Colombia and Canada In H2 2020

Kontrol Energy $KNR.ca Completes Acquisition of New Found Air $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 8:21 AM on Tuesday, August 4th, 2020
data:image/jpeg;base64,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
  • Completed the acquisition of New Found Air, previously announced on May 19, 2020
  • NFA leads a building energy and service platform that ensures the effective monitoring, operation and service of essential heating, cooling, ventilation, and utility systems.
  • The operations of NFA are diversified across the commercial, industrial, and multi-residential building sector
  • Acquisition Adds Recurring Revenue Service Platform

TORONTO, ON / August 4, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) announces that it has completed the acquisition of New Found Air (“NFA“), previously announced on May 19, 2020. NFA leads a building energy and service platform that ensures the effective monitoring, operation and service of essential heating, cooling, ventilation, and utility systems. The operations of NFA are diversified across the commercial, industrial, and multi-residential building sector.

“By closing the NFA acquisition we are well positioned to expand our technology and smart buildings solutions,” says Paul Ghezzi, CEO Kontrol Energy. “NFA has a blue-chip customer base and a service business with growing recurring revenues. These customers represent a new organic growth opportunity for Kontrol’s products and services.”

Kontrol has acquired 100% of the issued and outstanding shares of NFA for consideration of $2.7 Million; paid as $1.55 Million in cash, $750,000 vendor take-back loan having performance conditions, and the issuance of 727,272 Kontrol common shares at a deemed price of $0.55 cents per share.

NFA will initially be a separate operating subsidiary of Kontrol with an established strong management team which will remain in place. Over the coming six months there will be a transition to a full integration within Kontrol’s operating platform and the potential for cost synergies based on the consolidation of staff and administrative systems.

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at: www.sedar.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward Looking Statements:

Certain information included in this press release, including information relating to future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute “forward-looking statements”. Such forward-looking statements include, without limitation, statements regarding possible future acquisitions, organic growth, the provision of solutions to customers and Greenhouse Gas emissions reductions, proposed financial savings and sustainable energy benefits and energy monitoring. The global outbreak of COVID-19 (coronavirus) has had a significant impact on businesses through the restrictions put in place by the Canadian, provincial, and municipal governments regarding travel, business operations and isolation/quarantine orders. At this time, the extent of the impact of COVID-19 on the Company is unknown as this will depend on future developments that are highly uncertain and that cannot be predicted with confidence. These uncertainties arise from the inability to predict the ultimate geographic spread of the disease, and the duration of the outbreak, including the duration of travel restrictions, business closures or disruptions, and quarantine/isolation measures that are currently, or may be put, in place by Canada and other countries to fight the virus. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, lack of acquisition and investment opportunities or that such opportunities may not be concluded on reasonable terms, or at all, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

If you’re an investor in Canopy Growth $WEED.ca Check out our recent interview with Avicanna $AVCN.ca

Posted by AGORACOM-JC at 4:44 PM on Friday, July 31st, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

CONSUMER RETAIL – COSMETICS

  • The Only Known CBD Cosmetics Backed By Clinical Trials
  • Full Line Of High End CBD Based Skin Care Products
  • Already Commercializing In Colombia
  • Global Distribution In H2 2020 In United States, Europe and Canada
    • Canadian Distribution Through Shoppers Drug Mart

AGORACOM Welcomes Kontrol Energy $KNR.ca The Google NEST of Smart Building Technology $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 9:23 AM on Friday, July 31st, 2020
data:image/jpeg;base64,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

KNR:CSE / KNRLF:OTCQB /  1k8:Frankfurt

If Google NEST is the leader in smart home technology, Kontrol Energy is the small cap leader in smart building technology

  • Established Blue Chip Customer Base includes:
    • Beyond Meat
    • Oxford Properties
    • Brookfield Asset Management
    • Telus
    • Suncor Energy
    • ….. Many More
  •  Signed Major Deal With Toyota (Tsusho Canada)
    • Targeting 200 Plants Requiring Up To $1 Million Each In Automation Retrofits
  • MOU With Global European HVAC OEM
  • Strong Revenue Growth and Recurring
    • $1.96M in 2016 to $14.6M in 2019 (organic & acquisition)
    • 50% of revenues are repeat orders from existing customers
    •  20% of revenues recurring (software and service)
    • 40% ROI To Customer = Average Of 2-3 Year Payback
  • 44% Insider Ownership – Putting Their Money Where Their Mouth Is
  • Completed 5 Acquisitions Already
    • Announced Intent To Acquire Company With $3.7M Revenue / $843,000 Net
Kontrol-Blue-chip

SEEING IS BELIEVING